NA
HIMS icon

Navellier & Associates’s Hims & Hers Health HIMS Stock Holding History

Navellier & Associates’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,235
Closed -$365K – 341
2025
Q4 		$365K Sell
11,235
-81,442
-88% -$3.49M 0.04% 257
2025
Q3 		$5.26M Buy
92,677
+10,013
+12% +$513K 0.53% 44
2025
Q2 		$4.12M Buy
82,664
+75,261
+1,017% +$3.4M 0.51% 54
2025
Q1 		$310K Buy
+7,403
New +$275K 0.04% 251

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DE
Defiance ETFs New York $7.37B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Navellier & Associates's HIMS Position: Q1 2026 in Review

Navellier & Associates sold out of Hims & Hers Health (HIMS) in Q1 2026, closing a stake of 11,235 shares — an estimated $365K sold.

Navellier & Associates first reported a position in HIMS in Q1 2025 and held it in 4 quarters. The position peaked at $5.26M in Q3 2025. 436 funds tracked by Wall St. Rank hold HIMS as of Q1 2026.

  • Navellier & Associates reported no remaining Hims & Hers Health position as of Q1 2026 after selling out during the quarter.
  • Navellier & Associates sold 11,235 Hims & Hers Health shares in Q1 2026, an estimated $365K.
  • Navellier & Associates first reported a position in Hims & Hers Health in Q1 2025 and held it in 4 quarters.
  • Navellier & Associates's Hims & Hers Health position peaked at $5.26M in Q3 2025.
  • 436 funds tracked by Wall St. Rank held Hims & Hers Health as of Q1 2026.

Based on Navellier & Associates's 13F filing for Q1 2026, filed 7 May 2026.